Spots Global Cancer Trial Database for bone marrow ablation with stem cell support
Every month we try and update this database with for bone marrow ablation with stem cell support cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | NCT00003941 | Mediastinal Can... Metastatic Canc... Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide ifosfamide bone marrow abl... peripheral bloo... | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | NCT00005987 | Multiple Myelom... | carmustine cyclophosphamid... dexamethasone etoposide filgrastim mitoxantrone hy... recombinant int... sargramostim bone marrow abl... peripheral bloo... radiation thera... | - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia | NCT00003619 | Chronic Myelopr... Leukemia Myelodysplastic... Thrombocytopeni... | filgrastim vitamin E busulfan cytarabine etoposide fludarabine pho... isotretinoin topotecan hydro... bone marrow abl... peripheral bloo... | 19 Years - 90 Years | National Cancer Institute (NCI) | |
| Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00002649 | Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... | aldesleukin filgrastim cyclophosphamid... etoposide radiation thera... peripheral bloo... bone marrow abl... | 16 Years - 60 Years | National Cancer Institute (NCI) | |
| Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma | NCT00008008 | Brain and Centr... | filgrastim sargramostim cyclophosphamid... thiotepa autologous bone... bone marrow abl... peripheral bloo... | - | National Cancer Institute (NCI) | |
| Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission | NCT00101140 | Adult Acute Ery... Adult Acute Mon... Adult Acute Mye... | anti-thymocyte ... fludarabine pho... thiotepa biological ther... bone marrow abl... chemotherapy non-specific im... peripheral bloo... radiation thera... | 18 Years - 59 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | NCT00002697 | Lymphoma | filgrastim sargramostim carboplatin etoposide ifosfamide autologous bone... bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 65 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma | NCT00028886 | Multiple Myelom... | filgrastim recombinant int... cyclophosphamid... dexamethasone doxorubicin hyd... melphalan thalidomide vincristine sul... bone marrow abl... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00004188 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis | NCT00007995 | Multiple Myelom... | filgrastim recombinant int... sargramostim busulfan cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | NCT00002948 | Unspecified Adu... | filgrastim topotecan hydro... bone marrow abl... peripheral bloo... | 18 Years - | Yale University | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | NCT00005589 | Lymphoma | filgrastim rituximab carmustine cyclophosphamid... cytarabine etoposide melphalan bone marrow abl... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00002522 | Lymphoma | cisplatin cyclophosphamid... etoposide autologous bone... bone marrow abl... peripheral bloo... syngeneic bone ... radiation thera... | 15 Years - 70 Years | Temple University | |
| Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | NCT00003397 | Lymphoma | filgrastim rituximab sargramostim carmustine cisplatin cyclophosphamid... dexamethasone etoposide gemcitabine hyd... melphalan paclitaxel bone marrow abl... peripheral bloo... | 18 Years - 75 Years | University of Maryland, Baltimore | |
| Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | NCT00030719 | Neuroblastoma | filgrastim monoclonal anti... busulfan carboplatin cyclophosphamid... etoposide isotretinoin melphalan vincristine sul... bone marrow abl... conventional su... peripheral bloo... radiation thera... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | NCT00025636 | Lymphoma | filgrastim carmustine cisplatin cyclophosphamid... cytarabine dexamethasone etoposide melphalan methotrexate vincristine sul... bone marrow abl... peripheral bloo... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer | NCT00248430 | Graft Versus Ho... Leukemia Lymphoma Multiple Myelom... | aldesleukin therapeutic all... melphalan bone marrow abl... peripheral bloo... | 18 Years - 69 Years | Fred Hutchinson Cancer Center | |
| High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | NCT00003392 | Breast Cancer | filgrastim carboplatin cyclophosphamid... melphalan paclitaxel bone marrow abl... peripheral bloo... | 18 Years - 65 Years | UNC Lineberger Comprehensive Cancer Center | |
| Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma | NCT00003152 | Lymphoma | filgrastim recombinant int... cyclophosphamid... prednisone vincristine sul... autologous bone... bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 65 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | NCT00003392 | Breast Cancer | filgrastim carboplatin cyclophosphamid... melphalan paclitaxel bone marrow abl... peripheral bloo... | 18 Years - 65 Years | UNC Lineberger Comprehensive Cancer Center | |
| Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | NCT00002594 | Brain Tumor Central Nervous... | Sargramostim cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 2 Years - 25 Years | Children's Oncology Group | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | NCT00005589 | Lymphoma | filgrastim rituximab carmustine cyclophosphamid... cytarabine etoposide melphalan bone marrow abl... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | NCT00030719 | Neuroblastoma | filgrastim monoclonal anti... busulfan carboplatin cyclophosphamid... etoposide isotretinoin melphalan vincristine sul... bone marrow abl... conventional su... peripheral bloo... radiation thera... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00002649 | Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... | aldesleukin filgrastim cyclophosphamid... etoposide radiation thera... peripheral bloo... bone marrow abl... | 16 Years - 60 Years | National Cancer Institute (NCI) | |
| High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery | NCT00004921 | Ovarian Cancer | filgrastim carboplatin cyclophosphamid... melphalan paclitaxel adjuvant therap... bone marrow abl... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | NCT00002598 | Leukemia | recombinant int... sargramostim cyclophosphamid... cytarabine etoposide methotrexate mitoxantrone hy... bone marrow abl... radiation thera... | 16 Years - | Memorial Sloan Kettering Cancer Center | |
| Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | NCT00003401 | Multiple Myelom... | carmustine cisplatin cyclophosphamid... dexamethasone etoposide gemcitabine hyd... melphalan paclitaxel bone marrow abl... peripheral bloo... | 18 Years - 70 Years | University of Maryland, Baltimore | |
| Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | NCT00005987 | Multiple Myelom... | carmustine cyclophosphamid... dexamethasone etoposide filgrastim mitoxantrone hy... recombinant int... sargramostim bone marrow abl... peripheral bloo... radiation thera... | - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma | NCT00028665 | Lymphoma | filgrastim rituximab carmustine cisplatin cyclophosphamid... etoposide bone marrow abl... peripheral bloo... radiation thera... | 12 Years - 65 Years | Case Comprehensive Cancer Center | |
| Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia | NCT00275015 | Chronic Lymphoc... | filgrastim carmustine cyclophosphamid... cytarabine dexamethasone etoposide fludarabine pho... melphalan bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 60 Years | German CLL Study Group | |
| Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma | NCT00028886 | Multiple Myelom... | filgrastim recombinant int... cyclophosphamid... dexamethasone doxorubicin hyd... melphalan thalidomide vincristine sul... bone marrow abl... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00002522 | Lymphoma | cisplatin cyclophosphamid... etoposide autologous bone... bone marrow abl... peripheral bloo... syngeneic bone ... radiation thera... | 15 Years - 70 Years | Temple University | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | NCT00003852 | Childhood Germ ... Extragonadal Ge... Ovarian Cancer Testicular Germ... | filgrastim carboplatin cyclophosphamid... epirubicin hydr... etoposide ifosfamide paclitaxel thiotepa bone marrow abl... peripheral bloo... | 15 Years - 120 Years | UNICANCER | |
| Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | NCT00003401 | Multiple Myelom... | carmustine cisplatin cyclophosphamid... dexamethasone etoposide gemcitabine hyd... melphalan paclitaxel bone marrow abl... peripheral bloo... | 18 Years - 70 Years | University of Maryland, Baltimore | |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis | NCT00007995 | Multiple Myelom... | filgrastim recombinant int... sargramostim busulfan cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma | NCT00046852 | Infection Multiple Myelom... | filgrastim pneumococcal po... therapeutic aut... therapeutic tum... carmustine cyclophosphamid... melphalan bone marrow abl... peripheral bloo... | 18 Years - 80 Years | University of Maryland, Baltimore | |
| Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission | NCT00101140 | Adult Acute Ery... Adult Acute Mon... Adult Acute Mye... | anti-thymocyte ... fludarabine pho... thiotepa biological ther... bone marrow abl... chemotherapy non-specific im... peripheral bloo... radiation thera... | 18 Years - 59 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer | NCT00002931 | Brain and Centr... Extragonadal Ge... Ovarian Cancer Teratoma Testicular Germ... | filgrastim carboplatin etoposide ifosfamide paclitaxel autologous bone... bone marrow abl... | 16 Years - 120 Years | City of Hope Medical Center | |
| Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors | NCT00003846 | Brain and Centr... Neuroblastoma | filgrastim carboplatin cyclophosphamid... thiotepa vincristine sul... bone marrow abl... peripheral bloo... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | NCT00003215 | Lymphoma | filgrastim CHOP regimen cyclophosphamid... cytarabine doxorubicin hyd... etoposide leucovorin calc... melphalan methotrexate methylprednisol... mitoxantrone hy... prednisone therapeutic hyd... vincristine sul... bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 60 Years | Swiss Group for Clinical Cancer Research | |
| Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | NCT00011921 | Lung Cancer | filgrastim carboplatin epirubicin hydr... etoposide etoposide phosp... ifosfamide paclitaxel autologous bone... bone marrow abl... peripheral bloo... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma | NCT00217438 | Refractory Mult... Stage II Multip... Stage III Multi... | melphalan amifostine trih... peripheral bloo... fluorescence in... bone marrow abl... | 18 Years - 70 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant | NCT00417053 | Neuroblastoma | filgrastim busulfan carboplatin cyclophosphamid... doxorubicin hyd... etoposide phosp... melphalan vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 1 Year | National Cancer Institute (NCI) | |
| Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors | NCT00003846 | Brain and Centr... Neuroblastoma | filgrastim carboplatin cyclophosphamid... thiotepa vincristine sul... bone marrow abl... peripheral bloo... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors | NCT00002594 | Brain Tumor Central Nervous... | Sargramostim cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 2 Years - 25 Years | Children's Oncology Group | |
| Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | NCT00025636 | Lymphoma | filgrastim carmustine cisplatin cyclophosphamid... cytarabine dexamethasone etoposide melphalan methotrexate vincristine sul... bone marrow abl... peripheral bloo... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | NCT00003401 | Multiple Myelom... | carmustine cisplatin cyclophosphamid... dexamethasone etoposide gemcitabine hyd... melphalan paclitaxel bone marrow abl... peripheral bloo... | 18 Years - 70 Years | University of Maryland, Baltimore | |
| Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia | NCT00003727 | Leukemia | filgrastim recombinant int... sargramostim therapeutic aut... carmustine cyclophosphamid... etoposide gemcitabine hyd... melphalan bone marrow abl... in vitro-treate... | - 120 Years | University of Maryland, Baltimore | |
| Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission | NCT00101140 | Adult Acute Ery... Adult Acute Mon... Adult Acute Mye... | anti-thymocyte ... fludarabine pho... thiotepa biological ther... bone marrow abl... chemotherapy non-specific im... peripheral bloo... radiation thera... | 18 Years - 59 Years | Eastern Cooperative Oncology Group | |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer | NCT00007982 | Brain and Centr... Head and Neck C... Lymphoma | filgrastim carmustine cisplatin cyclophosphamid... etoposide thiotepa adjuvant therap... autologous bone... bone marrow abl... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma | NCT00008008 | Brain and Centr... | filgrastim sargramostim cyclophosphamid... thiotepa autologous bone... bone marrow abl... peripheral bloo... | - | National Cancer Institute (NCI) | |
| Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation | NCT00052884 | Drug/Agent Toxi... Multiple Myelom... | filgrastim amifostine trih... melphalan bone marrow abl... peripheral bloo... | 18 Years - 70 Years | Eastern Cooperative Oncology Group | |
| Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors | NCT00003846 | Brain and Centr... Neuroblastoma | filgrastim carboplatin cyclophosphamid... thiotepa vincristine sul... bone marrow abl... peripheral bloo... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
| Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma | NCT00217438 | Refractory Mult... Stage II Multip... Stage III Multi... | melphalan amifostine trih... peripheral bloo... fluorescence in... bone marrow abl... | 18 Years - 70 Years | Fred Hutchinson Cancer Center | |
| Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | NCT00012051 | Lymphoma | filgrastim rituximab carmustine cisplatin cytarabine dexamethasone etoposide ifosfamide melphalan methotrexate bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | NCT00182793 | Breast Cancer | trastuzumab carboplatin cyclophosphamid... melphalan thiotepa adjuvant therap... autologous-auto... bone marrow abl... radiation thera... | - 65 Years | City of Hope Medical Center | |
| Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | NCT00003401 | Multiple Myelom... | carmustine cisplatin cyclophosphamid... dexamethasone etoposide gemcitabine hyd... melphalan paclitaxel bone marrow abl... peripheral bloo... | 18 Years - 70 Years | University of Maryland, Baltimore |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
